Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
A multi-institutional study in Taiwan by Lin and colleagues found that GLP-1RA users were more likely than sodium-glucose cotransporter 2 inhibitors (SGLT-2I) users to develop PDR or require interventions for DR complications
These medications are supported by extensive randomized controlled trial data and are recommended by the American Diabetes Association (ADA) as preferred agents for many patients with type 2 diabetes, particularly those with established cardiovascular disease or chronic kidney disease
More on that later
Civil Engineering, UCLA Last updated: August 2026 Human-researched and AI-assisted with full editorial review
US$ 23.87
US$ 23.13
US$ 26.15
US$ 27.31
US$ 28.89
US$ 22.25
